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Abstract
Mammal adipose tissues require mitochondrial activity for proper development and differentiation. The components of the
mitochondrial respiratory chain/oxidative phosphorylation system (OXPHOS) are encoded by both mitochondrial and
nuclear genomes. The maintenance of mitochondrial DNA (mtDNA) is a key element for a functional mitochondrial oxidative
activity in mammalian cells. To ascertain the role of mtDNA levels in adipose tissue, we have analyzed the alterations in
white (WAT) and brown (BAT) adipose tissues in thymidine kinase 2 (Tk2) H126N knockin mice, a model of TK2 deficiency-
induced mtDNA depletion. We observed respectively severe and moderate mtDNA depletion in TK2-deficient BAT and WAT,
showing both tissues moderate hypotrophy and reduced fat accumulation. Electron microscopy revealed altered
mitochondrial morphology in brown but not in white adipocytes from TK2-deficient mice. Although significant reduction in
mtDNA-encoded transcripts was observed both in WAT and BAT, protein levels from distinct OXPHOS complexes were
significantly reduced only in TK2-deficient BAT. Accordingly, the activity of cytochrome c oxidase was significantly lowered
only in BAT from TK2-deficient mice. The analysis of transcripts encoding up to fourteen components of specific adipose
tissue functions revealed that, in both TK2-deficient WAT and BAT, there was a consistent reduction of thermogenesis
related gene expression and a severe reduction in leptin mRNA. Reduced levels of resistin mRNA were found in BAT from
TK2-deficient mice. Analysis of serum indicated a dramatic reduction in circulating levels of leptin and resistin. In summary,
our present study establishes that mtDNA depletion leads to a moderate impairment in mitochondrial respiratory function,
especially in BAT, causes substantial alterations in WAT and BAT development, and has a profound impact in the endocrine
properties of adipose tissues.
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Introduction
Mitochondrial function is essential for the development and
differentiation of the two types of adipose tissue in mammals,
brown adipose tissue (BAT) and white adipose tissue (WAT). It has
long been recognized that mitochondrial activity is a major
component of the differentiated phenotype of BAT, as it provides
the oxidative activity required for the thermogenic function of this
type of adipose tissue. In contrast, the relevance of mitochondria to
WAT function was often neglected. Several recent reports,
however, have established the importance of mitochondrial
biogenesis as part of the differentiation of the white adipose cell
and the acquisition of its specific metabolic features [1,2,3,4].
The molecular machinery of the mammalian mitochondrial
respiratory chain and oxidative phosphorylation (OXPHOS)
system has the unique feature of being encoded by two distinct
genomes, the nuclear and the mitochondrial genome. The
mitochondrial DNA (mtDNA) encodes 13 subunits of OXPHOS
complexes I, III, IV and V that are essential for the enzymatic
function of the OXPHOS system. Thus, coordinate expression of
the OXPHOS proteins encoded by the nuclear DNA (nDNA) and
mtDNA genes is required for functional mitochondrial oxidative
activity [5,6].
Alterations in mtDNA, from pathogenic point mutations to
abnormally low amounts of mtDNA (mtDNA depletion), have
been reported to cause multiple pathologies. These usually
manifest as neurodegenerative and neuromuscular diseases, but
there are also indications that altered mtDNA may lead to
disturbances in adipose tissue [7]. Several reports have indicated
associations of mtDNA polymorphic mutated forms with obesity
and type II diabetes [8,9,10,11]. However, the most-reported
relationship between adipose tissue alterations and mtDNA
depletion has been the lipodystrophy syndrome that appears in
HIV-1-infected patients undergoing antiretroviral treatment. In
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these patients, the combination of viral infection and secondary
effects of the treatment with inhibitors of the viral reverse
transcriptase leads to abnormal mtDNA replication and a
profound depletion of mtDNA levels in several tissues, including
fat. This is associated with massive alterations of adipose tissue
distribution, subcutaneous lipoatrophy, visceral adipose tissue
hypertrophy and, in some cases, lipomatosis. Moreover, the
endocrine properties of these patients are also perturbed and they
show frequently abnormal low levels of the adipokines adiponectin
and leptin [12,13]. The mechanistic processes linking mtDNA
depletion with specific alterations in adipose tissue mass,
distribution and endocrine function are poorly known.
Recently, murine models of mitochondrial DNA depletion have
been developed through targeted ablation of the mitochondrial
thymidine kinase 2 gene (Tk2) or gene replacement with a non-
functional form [14,15]. TK2 is responsible for providing
phosphorylated deoxythymidine within mitochondria in differen-
tiated, non-proliferating, cells and tissues. Accordingly, TK2 is
highly expressed in post-mitotic cells, in which the cytosolic form
of thymidine kinase, TK1, is poorly expressed. By providing the
deoxynucleotides required for mtDNA replication, TK2 activity
plays an essential role in maintaining appropriate levels of
mtDNA. Thus, null mutations of the TK2 gene, such as those
encoding the H121N mutant, lead to mtDNA depletion and
multiple neuromuscular pathologies in patients [16,17,18,19,20].
Experimental inactivation of the Tk2 gene in mice partially mimics
these alterations [14,15]. Thus, both targeted invalidation of the
Tk2 gene (Tk2-knockout) [15], and knockin of the enzymatically
null H126N form of Tk2 [14] cause early mortality in mice. It has
been proposed that this is attributable to neuromuscular failure
[14]. Moreover, the cellular morphology of the brain, spinal cord
[14], and brown adipose tissue [15] is altered by either mutation.
However, in either model, the impact of TK2 loss-of-function on
mtDNA depletion in distinct tissues is highly variable. Profound
mtDNA loss occurs in neural tissue but only very moderate
depletion is evident in the liver or kidney.
TK2 loss-of-function rodent models may be useful tools for
investigating the role of mtDNA depletion in adipose tissue. In the
present study, we have counted for that aim with mice
homozygous for knockin of the enzymatically null H126N Tk2
mutant, homologous to the pathological H121N TK2 mutation in
humans. We have determined to what extent TK2- deficiency
alters mtDNA levels in WAT and BAT, and the consequences on
the size and function of adipose tissue depots.
Materials and Methods
Ethics statement
Mice were cared for and used in accordance with European
Community Council Directive 86/609/EEC and approved by the
Institutional Animal Care and Use Committee of the University of
Barcelona (Approval no: DMAH 4100).
Animals and tissue collection
Homozygous Tk2 H126N knockin (Tk2-/-) mice were studied
when thirteen-day-old, the age at which mice had not already
developed over neuromuscular disease [14]. Tk2-/- mice and wild-
type (Tk2+/+) littermates were sacrificed, and interscapular brown
(BAT) and anterior subcutaneous white (WAT) adipose tissue
depots were dissected and frozen in liquid nitrogen. A small piece
of tissue was separated, cut up into pieces, and stored at 4uC in
fixation buffer (2% paraformaldehyde, 2.5% glutaraldehyde,
0.1 M phosphate buffer, pH 7.4) for subsequent transmission
electron microscopy analyses. Newborn (1-day-old) Tk2-/- and
Tk2+/+ mice were also sacrificed to obtain BAT. For development
studies, BAT and WAT from C57BL/6J wild-type mice were also
collected.
Preparation of tissue samples
For nucleic acid analyses, tissue samples (15–60 mg) were
homogenized using a Polytron device (Ultra-Turrax, IKA
Laboratory Equipment, Staufen, Germany), RNA was isolated
using a single-column commercial kit (NucleoSpin, Macherey-
Nagel GmbH and Co., Du¨ren, Germany), and DNA was isolated
using a phenol/chloroform extraction method. DNA and RNA
were quantified spectrophotometrically (NanoDrop, Thermo
Scientific, Waltham, MA, USA). For protein analyses, 15–40-mg
tissue samples were homogenized in 300 ml of protein lyses buffer
(20 mM Tris-HCl pH 7.4, 40 mM KCl, 2 mM EGTA, 5 mM
PMSF) and protein was quantified using the Bradford method
(Bio-Rad, Hercules, CA, USA). Tissue lipid content was measured
gravimetrically after extraction, in accordance with previously
described procedures [21].
Evaluation of serum parameters
Glucose and lactate levels were measured in serum using
Accutrend Technology (Roche Diagnostics, Basel, Switzerland).
Adiponectin levels were determined by immunoassay using a
commercial enzyme-linked immunosorbent assay kit (Linco
Research, Saint Charles, MO, USA). Leptin,, interleukin-6, total
plasminogen activator inhibitor type-1 and resistin were quantified
in 20 ml of plasma using a multiplex system (Linco Research/
Millipore, Saint Charles, MO, USA) and a Luminex100ISv2
equipment.
Optical and transmission electron microscopy analyses
Fixed BAT and WAT samples were post-fixed in 1% osmium
tetroxide and 0.8% FeCNK in phosphate buffer 0.1 M. After
dehydration in a graded acetone series, tissue samples were
embedded in Spurr resin. Ultrathin sections were obtained using
Table 1. Body and tissue weights, protein and lipid content
in 13-day-old Tk2 H126N knockin mice (Tk2-/-).
Tk2+/+ Tk2-/-
Body weight (g) 6.360.2 5.560.3**
WAT
Weight (mg) 55.966.1 28.965.5**
Weight body weight (mg/g) 9.060.8 5.561.0*
Protein content (mg) 1.260.1 0.860.2
Protein content (mg/g tissue) 22.963.1 29.164.7
Lipid content (mg) 51.466.1 26.063.8**
Lipid content (mg/g tissue) 919687 899692
BAT
Weight (mg) 45.862.7 33.462.2**
Weight/body weight (mg/g) 7.260.3 6.360.5
Protein content (mg) 1.760.1 1.660.2
Protein content (mg/g tissue) 38.665.3 47.767.4
Lipid content (mg) 26.662.3 16.460.7**
Lipid content (mg/g tissue) 580650 490620
Values are means6SEM of 7–12 mice/group.
*P,0.05; **P,0.01
doi:10.1371/journal.pone.0029691.t001
Adipose Tissue in Tk2-Deficient Mice
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Figure 2. Morphology of BAT and mitochondria in brown adipocytes from Tk2 H126N knockin mice. A. Optical microscopy (top) and
transmission electron microscopy analysis (bottom) of BAT from Tk2+/+ and Tk2-/- mice. Scale bars: 2 mm (bottom panel). The image is representative
of six independent slides from three different animals for each genotype. B. Stereological analyses of mitochondrial cristae density and relative
mitochondrial volume from Tk2+/+ and Tk2-/- mice. Bars are means 6 SEM data expressed as inner mitochondrial versus external mitochondrial
membranes surface ratio (mm2/mm2), and mitochondrial volume versus non-fat cytoplasm volume (%) (*P,0.05 for Tk2+/+ vs. Tk2-/-; 8 slides/group),
respectively.
doi:10.1371/journal.pone.0029691.g002
Figure 1. Morphology of WAT and mitochondria in white adipocytes from Tk2 H126N knockin mice. A. Optical microscopy (top) and
transmission electron microscopy analysis (bottom) of WAT from Tk2+/+ and Tk2-/- mice. Scale bars: 1 mm (bottom panel). The image is representative
of eight independent slides from three different animals for each genotype. B. White adipocyte size analysis from Tk2+/+ and Tk2-/- mice. Bars are
means 6 SEM data expressed as cell surface area (mm2) (***P,0.001 for Tk2+/+ vs. Tk2-/-; 8 slides/group).
doi:10.1371/journal.pone.0029691.g001
Adipose Tissue in Tk2-Deficient Mice
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an Ultracut UCT (Leica Microsystems GmbH, Wetzlar, Ger-
many) and examined under an optical microscope. Samples were
subsequently stained with uranyl acetate and lead citrate, and
examined by transmission electron microscopy (JEOL 1010,
Tokyo, Japan). White adipocyte area determination was per-
formed using the ImageJ analysis software. For stereological
analysis, the proportion of mitochondrial volume with respect to
non-fat cell volume (Volmit/Volnon-fat cell) was estimated using the
volume density method [22]; surface density was calculated
employing a vertical sections method [22,23].
mRNA expression analyses
Total RNA (0.5 mg) was transcribed into cDNA using Multi-
Scribe reverse transcriptase and random-hexamer primers (Taq-
Man Reverse Transcription Reagents; Applied Biosystems, Foster
City, CA, USA). For quantitative mRNA expression analyses,
TaqMan reverse transcriptase-polymerase chain reaction (RT-
PCR) was performed on the ABI PRISM 7700HT sequence
detection system (Applied Biosystems). Reactions were performed
in a final volume of 20 ml using TaqMan Universal PCR Master
Mix, No-AmpErase UNG reagent, and the specific primer pair/
probe sets (TaqMan Gene Expression Assays; Applied Biosystems)
(see Table S1). On-Demand (Custom TaqMan Gene Expression
Assays, Applied Biosystems) primers and probes were designed for
the quantification of NADH dehydrogenase subunit 1 (ND1),
cytochrome c oxidase subunit I (COXI) and cytochrome b
(CYTB) mRNAs and mtDNA abundance. Sequences were 59-
GAG CCT CAA ACT CCA AAT ACT CAC T-39 (forward), 59-
GAA CTG ATA AAA GGA TAA TAG CTA TGG TTA CTT
CA-39 (reverse) and 59-CCG TAG CCC AAA CAA T-39 (FAM-
labeled probe) for ND1; 59-GGT GCA ATT AAT TTT ATT
ACC ACT ATT ATC AAC ATG A-39 (forward), 59-GGC TGT
AAT AAG TAC GGA TCA GAC A-39 (reverse) and 59-CCC
CAG CCA TAA CAC A-39 (FAM-labeled probe) for COX1; and
59-CCC AAC AGG ATT AAA CTC AGA TGC A-39 (forward),
59-CTA GGG TTA TGA GAA TTA AGA ATA TGA TTA
GGA TAC CT-39 (reverse) and 59-TTC CAT TTC ACC CCT
ACT ATA CA-39 (FAM-labeled probe) for CYTB. Eukaryotic
rRNA (18S; Hs99999901_s1) was used as reference control, and
main results were confirmed by the use of the cyclophilin A
Figure 3. Mitochondrial DNA and OXPHOS transcript levels in WAT and BAT from Tk2 H126N knockin mice. mtDNA relative
abundance, and mtDNA- and nDNA-encoded transcript levels in WAT and BAT from Tk2+/+ and Tk2-/- 13-day-old mice. Bars are means 6 SEM data
expressed as percentage values relative to wild-type controls (*P,0.05; **P,0.01 for Tk2+/+ vs. Tk2-/-; 7-12 mice/group). ND1, NADH dehydrogenase
subunit 1; CYTB, cytochrome b; COI, cytochrome c oxidase subunit 1; Uqcrc1, ubiquinol-cytochrome c reductase core protein 1; Cycs, cytochrome c
somatic; Cox4i1, cytochrome c oxidase subunit 4 isoform 1; Atp5g3, ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9),
isoform 3.
doi:10.1371/journal.pone.0029691.g003
Adipose Tissue in Tk2-Deficient Mice
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transcript (Ppia; Mm02342430_g1) as an alternative housekeeping
control.
Assessment of relative mtDNA content
mtDNA was quantified by quantitative real-time PCR quanti-
fication of CYTB gene relative to nuclear DNA, determined by
quantitative real-time PCR quantification of the Cebpa gene [24].
Western blot and immunodetection
For Western blot analyses, cell lysates containing 15–30 mg
protein were resolved by sodium dodecyl sulfate-poliacrylamide
gel electrophoresis on 15% gels and transferred to polyvinylidene
fluoride membranes (Immobilon, Millipore, Billerica, MA, USA).
For immunodetection of OPA1, 7.5% poliacrylamide gels were
used. Membranes were incubated with blocking buffer (5% dried
milk/0.1% Tween-20/phosphate-buffered saline [PBS]) for
1 hour at room temperature, and incubated with the correspond-
ing primary antibodies in 1% dried milk/0.1% Tween-20/PBS
overnight at 4uC (see Table S2). Primary antibodies were
immunodetected using polyclonal anti-mouse (Bio-Rad Laborato-
ries, S.A., Spain) or anti-rabbit (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA) secondary horseradish peroxidase-
conjugated antibodies. Enhanced chemiluminescence reagents
were used to analyze the immunoreactive signals (Immobilon
Western, Millipore, Billerica, MA, USA). All membranes were
stained with Coomassie Brilliant Blue R-250 (Sigma Chemical
Co., St. Louis, MO, USA) to verify equal protein loading.
Immunoreactive signals were analyzed densitometrically using
Multi Gauge v3.0 software (Fujifilm, Madrid, Spain).
Mitochondrial respiratory chain activities and caspase-9
activity
Complex I+III activity was determined as the velocity of
reduction of cytochrome c by the enzyme NADH cytochrome c
reductase in the presence of NADH and rotenone. For this
purpose, changes in absorbance at 550 nm were measured with
Table 2. Expression of the mRNA for nuclear genes encoding proteins involved in mitochondrial function in WAT and BAT from
Tk2 knockin mice.
Tk2-/- vs. Tk2+/+ (%) P value
WAT
mtDNA expression regulation
Transcription factor A, mitochondrial (Tfam) 99 + 6 0.79
Transcription factor B1, mitochondrial (Tfb1m) 95 + 6 0.93
Transcription factor B2, mitochondrial (Tfb2m) 99 + 6 0.64
Mitochondrial ROS
Uncoupling protein-2 (Ucp2) 102 + 20 0.61
Superoxide dismutase 2 (Sod2) 90 + 13 0.62
Glutathione peroxidase4 (Gpx4) 88 + 7 0.46
Mitochondrial dynamics
Optic atrophy 1 (Opa1) 91 + 10 0.61
Mitofusin 2 (Mfn2) 119 + 18 0.63
BAT
mtDNA expression regulation
Transcription factor A, mitochondrial (Tfam) 82 + 7 0.34
Transcription factor B1, mitochondrial (Tfb1m) 87 + 4 0.15
Transcription factor B2, mitochondrial (Tfb2m) 92 + 7 0.64
Mitochondrial translation initiation factor 2 (Mtif2) 102 + 10 1.00
Mitochondrial translation initiation factor 3 (Mtif3) 84 + 14 0.66
Mitochondrial ROS
Uncoupling protein-2 (Ucp2) 112 + 14 0.53
Uncoupling protein-3 (Ucp3) 100 + 6 0.70
Superoxide dismutase 2 (Sod2) 67 + 4** 0.004
Glutathione peroxidase 4 (Gpx4) 83 + 6 0.09
Mitochondrial dynamics
Optic atrophy 1 (Opa1) 138 + 11* 0.04
Mitofusin 2 (Mfn2) 124 + 18 0.77
Growth hormone inducible transmembrane protein (Ghitm) 72 + 9* 0.04
Mitochondrial inner membrane protein (Immt) 55 + 4* 0.02
Values are expressed as means6SEM of the percent respect to control values that were set to 100 of 6–12 mice/group. P values for statistical comparisons are shown.
Bold lettering is depicted when differences were statistically significant.
*P,0.05; **P,0.01
doi:10.1371/journal.pone.0029691.t002
Adipose Tissue in Tk2-Deficient Mice
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and without rotenone [25]. Complex IV (cytochrome c oxidase)
activity was measured using reduced cytochrome c as a substrate.
Cytochrome c oxidation was monitored at 550 nm [26].
Complex V (ATP synthase) activity was determined using a
commercial kit (Novagen, Merck KGaA, Darmstadt, Germany).
Citrate synthase activity was used as a marker of mitochondrial
content. This enzyme catalyzes the acetyl-coenzyme A oxaloac-
etate reaction that yields citrate and coenzyme A. This latter
product was measured using 559-dithiobis-(2-nitrobenzoic acid);
the reaction was monitored at 412 nm [27]. Enzyme activity was
expressed per milligram protein. Protein content was determined
using the Coomassie Plus protein assay reagent (Pierce, Rockford,
IL, USA).
Caspase-9 activity was measured in tissue extracts (5–20 mg
protein/assay) using a luminescence-based system (Casapase-Glo 9
Assay, Promega, Madison, WI, USA). Data were expressed as
relative luminescence units (RLU) per mg of tissue protein.
Statistics
All values are given as means 6 SEM. Mann-Whitney
(nonparametric) test was used for statistical analyses. Grubbs’ test
was used to determine significant outliers (significance, al-
pha= 0.05). A P value of less than 0.05 was considered to be
significant.
Results
WAT and BAT hypotrophy in Tk2-/- mice
The weights of both, the anterior subcutaneous WAT and the
interscapular BAT depots were significantly lower in Tk2-/- mice
than in wild-type littermates. When expressed relative to body
weight, the difference remained but was statistically significant
only for WAT. The total lipid content in WAT and BAT was
significantly lower in Tk2-/- mice than in Tk2+/+ mice, and
accounted for most of the decrease in tissue weight in Tk2-/- mice.
Figure 4. Immunoblot analyses of selected mitochondrial proteins in WAT from Tk2 H126N knockin mice. A. Bars are means 6 SEM of
density of specific immunoblot signals normalized to total protein load (*P,0.05 for Tk2+/+ vs. Tk2-/-; 4-6 mice/group). B. Representative western blots
of OXPHOS proteins and the mitochondrial transcription factor TFAM. ATPsyn a (CV), ATP synthase subunit a (Complex V); Core 2 (CIII), Core 2 subunit
(Complex II); COI (CIV), cytochrome c oxidase subunit 1 (Complex IV); Ip30 kD (CII), 30 kD subunit (Complex II); ND6 (CI), NADH dehydrogenase
subunit 6 (Complex I); TFAM, mitochondrial transcription factor A.
doi:10.1371/journal.pone.0029691.g004
Adipose Tissue in Tk2-Deficient Mice
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Total protein content in WAT and BAT was not significantly
different between Tk2-/- and Tk2+/+ mice (Table 1).
Altered mitochondrial morphology in BAT from Tk2-/-
mice
Examination of WAT morphology by optical microscopy
revealed no evidence of any gross alterations in adipocyte size or
morphology (Fig. 1A, top). However, quantitative analysis of cell
surface area revealed a moderate but highly significant reduction
in adipocyte size in Tk2-/- mice (Fig. 1B). Transmission electron
microscopy (TEM) revealed no major changes in mitochondrial
morphology in WAT from Tk2-/- mice (Fig. 1A, bottom). Optical
microscopic examination also revealed no alteration in the gross
morphology of brown adipocytes in BAT from Tk2-/- mice
(Fig. 2A, top). However, examination of brown adipocytes by TEM
revealed abnormal development of mitochondria in Tk2-/- mice.
Clumps of densely packed mitochondria were evident in the
brown adipocytes of Tk2-/- mice (Fig. 2A, bottom) and quantitative
measurements revealed that mitochondria occupied a greater
proportion of the cytoplasmatic volume (Fig. 2B, bottom). However,
the mitochondria appeared to develop regularly, and contained
well-formed cristae, as evidenced by surface ratio quantification
data (Fig. 2B, top).
mtDNA depletion and impaired expression of mtDNA-
encoded transcripts in adipose tissues from Tk2-/- mice
mtDNA levels were determined in WAT and BAT from Tk2-/-
mice and their Tk2+/+ littermates. BAT from Tk2-/- mice showed a
dramatic reduction in abundance of mtDNA, which was decreased to
approximately 20% of the mtDNA levels in wild-type mice. A milder
reduction inmtDNA content was observed inWAT formTk2-/- mice
(Fig. 3). In BAT, the reduction in mtDNA levels was associated with a
significant reduction in transcript levels of the mtDNA-encoded ND1
gene. A significant reduction in the mtDNA-encoded CYTB mRNA
was observed in both WAT and BAT. In contrast, nDNA-encoded
components of the OXPHOS system (Uqcrc1, Cycs, Cox4i1, and
Atp5g3) were unaltered in both tissues (Fig. 3).
The levels of mtDNA in BAT could be analyzed in Tk2-/-
newborns, given that BAT, but not WAT, is already developed in
neonatal mice. There were no significant changes in mtDNA
Figure 5. Immunoblot analyses of selected mitochondrial proteins in BAT from Tk2 H126N knockin mice. A. Bars are means 6 SEM of
density of specific immunoblot signals normalized to total protein load (*P,0.05 for Tk2+/+ vs. Tk2-/-; 4-6 mice/group). B. Representative western
blots. ATPsyn a (CV), ATP synthase subunit a (Complex V); Core 2 (CIII), Core 2 subunit (Complex II); COI (CIV), cytochrome c oxidase subunit 1
(Complex IV); Ip30 kD (CII), 30 kD subunit (Complex II); ND6 (CI), NADH dehydrogenase subunit 6 (Complex I); OPA1, Optic atrophy 1 protein; TFAM,
mitochondrial transcription factor A; VDAC, voltage-dependent anion carrier; UCP1, uncoupling protein 1.
doi:10.1371/journal.pone.0029691.g005
Adipose Tissue in Tk2-Deficient Mice
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relative abundance or mtDNA-encoded transcript (CYTB) levels
in BAT from Tk2-/- pups respect to controls (data not shown).
Transcript levels of mitochondrial nDNA-encoded
transcripts in WAT and BAT from Tk2-/- mice
We further analyzed the transcript levels for up to eleven nuclear
genes involved in distinct aspects of WAT and BAT mitochondrial
functions. No statistically significant changes were found in WAT
from Tk2-/- mice compared to Tk2+/+ littermates in the expression
levels of transcripts encoding components of the mtDNA expression
machinery, of mitochondrial oxidative stress protection, or mito-
chondrial dynamics. In contrast, Tk2-/- mice showed an altered gene
expression in BAT of two genes involved in the oxidative stress and
mitochondrial dynamics. Sod2 mRNA levels were significantly
decreased in Tk2-/- compared to controls, whereas Opa1 transcript
levels appeared higher respect to wild-type littermates. Ghitm and
Immt transcripts were also significantly reduced. No changes were
found in BAT for the other genes analyzed (Table 2).
Levels of mitochondrial proteins, respiratory complex
activities and caspase-9 activity in adipose tissues from
Tk2-/- mice
We next analyzed whether the mild mtDNA depletion and
down-regulation of mtDNA-encoded transcripts in WAT from
Tk2-/- mice resulted in changes in the abundance of OXPHOS
proteins. The results indicated no impairment in the expression of
mtDNA- or nDNA-encoded OXPHOS protein components of
distinct respiratory complexes in WAT (Fig. 4). In contrast, the
levels of TFAM protein were dramatically reduced in WAT from
Tk2-/- mice (Fig. 4, right).
BAT from Tk2-/- mice showed a significant reduction in the
protein levels of the mtDNA-encoded proteins ND6 and COI.
Nuclear encoded OXPHOS protein levels were also reduced
(Fig. 5, left). A dramatic reduction of TFAM to nearly undetectable
levels was observed in BAT from Tk2-/- mice. Although there was
a trend towards reduced levels of UCP1 and VDAC proteins,
these differences did not reach statistical significance (Fig. 5, right).
No significant changes were found for OPA1 fusion protein
isoforms between Tk2-/- and wild-type mice (Fig. 5, right). These
data indicate that mtDNA depletion in Tk2-/- mice was associated
with a specific impairment in the expression of OXPHOS
components in BAT.
In order to determine whether these changes had consequences
for mitochondrial OXPHOS function, we analyzed the enzy-
matic activity of mitochondrial respiratory complexes. Whereas
there were no significant differences in complex I+III activity
(Fig. 6, top), there was a significant reduction in complex IV
(cytochrome c oxidase) activity in BAT from Tk2-/- mice
compared to controls (Fig. 6, bottom). When complex IV activity
was expressed as relative to citrate synthase activity, an index of
mitochondrial mass, activity levels remained lower, but the
difference was not statistically significant (Fig. 6, bottom, right).
Assessment of complex V (ATP synthase) activity indicated very
low enzymatic activity (in the 5–6 nmol/min/mg protein range)
in BAT from wild-type mice, in accordance with previous reports
[28], and no significant differences were found in Tk2-/- mice
(data not shown).
In order to explore whether alterations in mitochondrial
morphology and complex IV activity in BAT may result in
alterations in mitochondria-driven apoptotic activation, we mea-
sured caspase-9 activity. Results indicated no significant differences
between Tk2+/+ (12.661.2 RLU/mg protein) and Tk2-/- mice
(13.661.1 RLU/mg protein), consistently with the lack of morpho-
logical indications of apoptosis in the microscopy analysis of tissues.
Leptin and resistin depletion in serum from Tk2-/- mice
The analysis of serum adipokines revealed a strong reduction in
the levels of leptin and resistin in Tk2-/- mice compared to control
littermates. These changes occurred in the absence of significant
Figure 6. Mitochondrial respiratory complex activities in BAT
from Tk2 H126N knockin mice. Mitochondrial respiratory complex
I+III and complex IV (cytochrome c oxidase) activities in BAT from Tk2+/+
and Tk2-/- mice. The activity of each complex is expressed as nanomoles
of final product per minute (1 Unit) per milligram protein, and as mUnits
(or Units) of complex activity/Units of citrate synthase activity. Bars are
means 6 SEM (*P,0.05 for Tk2+/+ vs. Tk2-/-; 5–10 mice/group).
doi:10.1371/journal.pone.0029691.g006
Table 3. Serum parameters in 13-day-old Tk2 H126N knockin
mice (Tk2-/-).
Tk2+/+ Tk2-/-
Glucose (mg/dl) 139.80620.30 123.30617.37
Lactate (mM) 4.7861.41 4.6560.93
Adiponectin (mg/ml) 6.5560.46 5.3460.24
Interleukin-6 (pg/ml) 17.7763.65 11.1062.87
Leptin (ng/ml) 4.1160.68 0.9160.17**
PAI-1a (ng/ml) 2.3660.47 2.2060.76
Resistin (ng/ml) 5.2460.74 2.6560.57*
Values are means6SEM of 7–12 mice/group.
*P,0.05; **P,0.01
doi:10.1371/journal.pone.0029691.t003
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alterations in other circulating parameters, such as serum glucose,
or serum lactate. No changes were found in other adipokines, such
as adiponectin, or pro-inflammatory cytokines, such as interleukin-
6 and PAI-1a (Table 3).
Impaired expression of adipokine and thermogenesis-
related genes in WAT and BAT from Tk2-/- mice
Finally, we analyzed the transcript levels for up to 14 nuclear
genes involved in distinct aspects of WAT and BAT metabolism
and physiological functions. No statistically significant changes
were found in WAT or BAT from Tk2-/- mice respect to Tk2+/+
littermates for the expression of transcripts encoding components
of overall adipogenesis (Pparg, Cebpa, Cebpb) and of lipid
metabolism (Acox1, Fabp4, Pdk4) (Fig. 7, Fig. 8). In contrast, the
expression of two genes encoding proteins specifically involved in
thermogenesis, the uncoupling protein-1 (Ucp1) and the b3
adrenergic receptor (Adrb3) were significantly down-regulated in
WAT from Tk2-/- mice (Fig. 7). Moreover, Ucp1 and PGC-1a
transcripts were also down-regulated in BAT from Tk2-/- mice
(Fig. 8). An examination of the expression of Ucp1 and PGC-1a in
BAT from 1-day-old newborn mice revealed no significant
changes in Tk2-/- pups (Ucp1, 96%611% vs. wild-type; PGC-
1a, 128%69% vs. wild-type). Leptin mRNA levels showed a
dramatic reduction in WAT and BAT from Tk2-/- mice, whereas
resistin transcript levels were only reduced in BAT. No statistically
significant differences were found in WAT or BAT for adiponectin
mRNA expression levels between Tk2-/- mice and wild-type
littermates (Fig. 7, Fig. 8).
Developmental regulation of Tk2 gene expression and
mtDNA levels in BAT and WAT
We determined the profile of changes in Tk2 mRNA expression
and mtDNA abundance in adipose tissues throughout develop-
ment of wild-type mice. Tk2 mRNA levels were low in BAT from
fetuses at term and it increased progressively in neonates, reaching
adult levels shortly after birth. In 13 day-old mice, Tk2 mRNA
levels in BAT were already as high as in adults (Fig. 9, top).
However, in WAT from 13 day-old pups Tk2 mRNA levels had
not yet reached adult levels. These results were paralleled by
developmental changes in mtDNA levels: mtDNA abundance was
low in fetal BAT but had attained adult levels 13 days after birth.
In contrast, mtDNA levels in WAT were lower than in adult WAT
(Fig. 9, bottom).
Discussion
In the present study, Tk2-/- mice were used as a model to
investigate the role of mtDNA depletion in adipose tissues and to
establish the specific alterations in WAT and BAT that take place
as a consequence of TK2 loss-of-function and mtDNA depletion.
TK2 deficiency resulted in a moderate reduction in the amounts of
WAT and BAT in 13-day-old mice.
Figure 7. Expression of nuclear genes encoding proteins involved in adipogenesis, thermogenesis, and lipid metabolism in WAT
from TK2-deficient mice. Bars are means 6 SEM of the percent respect to control values that were set to 100 (*P,0.05; ***P,0.001 for Tk2+/+ vs.
Tk2-/-; 6–12 mice/group). Pparg, peroxisome proliferator activated receptor-c; Cebpa, CCAAT/enhancer-binding protein-a; Ucp1, uncoupling protein
1; PGC-1a, PPARc coactivator-1a; Adrb3, b3-adrenergic receptor; Dio-2, 59-deiodinase-2; Adipoq, adiponectin; Acox1, acyl CoA oxidase; Pdk4, pyruvate
dehydrogenase-kinase 4.
doi:10.1371/journal.pone.0029691.g007
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The extent of mtDNA depletion in BAT from 13-day-old Tk2-/-
mice was profound, about an 80–90%. This value was within the
range of that in other highly affected tissues, such as brain and
spinal cord, and was stronger than that in tissues such as liver and
kidney, which showed about 30–40% depletion in this rodent
model [14]. Remarkably, no such depletion was found in BAT
from 1-day-old Tk2-/- neonates, indicating that mtDNA depletion
in BAT develops during the postnatal period. This observation is
consistent with the profile of Tk2 expression during BAT
development, which showed a marked postnatal induction. During
the late fetal period, BAT develops and differentiates progressively
as a result of increased proliferation and differentiation of brown
adipocytes [29]. However, after birth, proliferative processes are
expected to be much reduced and BAT becomes an essentially
post-mitotic tissue. The increase in Tk2 gene expression in
postnatal BAT is likely to be associated with the post-mitotic
status of brown adipocytes after birth, and could explain why BAT
mtDNA replication becomes strongly dependent on TK2 activity
basically in the postnatal period.
The milder reduction in mtDNA levels in WAT may be related
to the delayed development of WAT compared to BAT in rodents.
It is known that there is almost no WAT in rodents at birth and,
two weeks later, WAT has only begun to develop [30]. This is
consistent by the already low levels of mtDNA and Tk2 gene
expression observed in WAT from 2-week-old mice compared to
that in adults. This could also explain a minor dependency of
WAT on TK2 activity in maintaining mtDNA levels during this
stage of development, when WAT is still proliferatively active.
The profound depletion of mtDNA in BAT resulted in a
reduction in the levels of mtDNA-encoded transcripts, as well as in
the corresponding mtDNA-encoded OXPHOS proteins. The
observed reduction in nDNA-encoded OXPHOS proteins, despite
unaltered transcript levels, might be secondary to the original
reduction in mtDNA-encoded proteins. Accordingly, impaired
synthesis of mtDNA-encoded proteins may alter the stoichiometry
of the subunit composition of OXPHOS complexes, resulting in
concomitantly lower levels of the nDNA-encoded OXPHOS
subunits. The net consequence of these alterations for mitochon-
drial respiratory complexes was a significant, although quantita-
tively moderate, reduction in complex IV activity.
Notably, TFAM protein levels, but not Tfam transcript levels,
were dramatically down-regulated in BAT. This may reflect the
known role of TFAM as an mtDNA-coating protein [31]. It has
been reported that mtDNA depletion in patients is accompanied
by low levels of TFAM without a decrease in its mRNA levels [32].
It is likely, therefore, that TFAM reduction was indirectly caused
by the reduction in mtDNA levels elicited by TK2 loss-of-function.
We have shown that mtDNA depletion is not associated with
massive alterations in white or brown adipocyte development or
cell morphology; instead, only a quantitative reduction in tissue
mass, mostly attributable to lower fat accretion. However, electron
microscopy revealed alterations in mitochondrial distribution in
brown adipocytes from Tk2-/- mice, essentially the presence of
clumps of highly packaged mitochondria in the cell cytoplasm
associated with an increase in mitochondrial volume within the
cell. This morphological abnormality is reminiscent of the
Figure 8. Expression of nuclear genes encoding proteins involved in adipogenesis, thermogenesis, and lipid metabolism in BAT
from TK2-deficient mice. Bars are means 6 SEM of the percent respect to control values that were set to 100 (*P,0.05 for Tk2+/+ vs. Tk2-/-; 8–
12 mice/group). Pparg, peroxisome proliferator activated receptor-c; Fabp4, fatty acid binding protein-4; Cebpa, CCAAT/enhancer-binding protein-a;
Cebpb, CCAAT/enhancer-binding protein-b; Adipoq, adiponectin; Ucp1, uncoupling protein 1; PGC-1a, PPARc coactivator-1a; Rip140, receptor
interacting protein 140 kD; Adrb3, b3-adrenergic receptor; Dio-2, 59-deiodinase-2; Acox1, acyl CoA oxidase; Pdk4, pyruvate dehydrogenase-kinase 4.
doi:10.1371/journal.pone.0029691.g008
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accumulation of aberrant mitochondria that appears in the muscle
of patients with some mtDNA diseases that lead to ragged-red
fibers [33]; or to the mitochondrial proliferation reported in the
adipose tissue from HIV-1 patients with lipodystrophy and
mtDNA depletion [34,35,36]. The impaired expression of
mitofilin (Immt) and MICS1 (Ghitm), marker genes for cristae
organization and remodeling, is compatible with altered mito-
chondrial morphology despite quantitative assessment of cristae
density did not evidence a significant change. However, the
expression patterns of components of the mitochondrial prolifer-
ation, such as VDAC, or of the mitochondrial fusion machinery,
such as OPA1, did not suggest massive enhancement of
mitochondrial proliferation or disruption of mitochondrial dy-
namics as a consequence of mtDNA depletion in BAT. Further
research will be required to establish the relationship between
mitochondrial morphological alterations and the mild alteration in
mitochondrial oxidative function in BAT from Tk2-/- mice.
When we explored the possibility that TK2 loss-of-function and
mtDNA depletion causes changes in specific adipocyte functions
two major alterations were observed. First, we found abnormally
down-regulation of marker genes of brown fat thermogenesis in
both BAT and WAT depots. This observation may be consistent
with the hypothermia previously reported in a similar Tk2-null
mouse model [15]. However, as such temperature decrease occurs
at an age very close to mortality, it is unclear whether hypothermia
may be a primary event or simply a consequence of ongoing
systemic breakdown attributable to neuromuscular disease. It may
be that, through unknown mechanisms, the reduced mtDNA
levels specific impairs the expression of thermogenesis-related
genes in adipocytes. However, in light of the multi-systemic
mtDNA depletion that occurs in Tk2-/- mice [14], other
possibilities should also be considered. For instance, BAT
thermogenic activity is known to be under the control of
sympathetic nervous system action on BAT [37]. Considering
that nervous tissue is among the most affected tissues in Tk2-/-
mice, the possibility that the reduction of thermogenic activity in
BAT was not a direct consequence of mtDNA depletion in brown
adipocytes, but was rather an indirect consequence of altered
sympathetic nervous system activity cannot be excluded. This
phenomenon, if confirmed, could be relevant to understanding the
impact of reduced mtDNA levels in humans, considering the
recent evidence for active BAT under the control of sympathetic
nervous system activity in adult humans [38,39].
A relevant finding in the present study was that mtDNA
depletion associated with TK2 deficiency causes a profound
hypoleptinemia in mice. This could not be simply attributed to
reduced amounts of adipose tissue, as there was a dramatic specific
impairment in leptin gene expression both in BAT and WAT.
Although in adult mice WAT instead of BAT is the main source of
leptin, in very young rodents BAT seems to contribute to leptin
synthesis and release [40,41]. The reasons by which mtDNA
depletion and mild respiratory activity reduction leads to such
specific impairment in leptin gene expression is unclear, as the
expression of known transcriptional activators of the leptin gene,
such as C/EBPa and PPARc [42,43], are not modified in adipose
tissue from Tk2-/- mice. It has been reported that the gene
expression for other adipokines, such as adiponectin, is strongly
influenced by reactive oxygen species-dependent signaling origi-
nating in mitochondria [44]. Further research will be required to
determine the mechanisms for altered mitochondrial retrograde
signaling in adipose tissue from Tk2-/- mice in response to mtDNA
depletion. In is indeed true that hypoleptinemia may deleteriously
affect overall energy metabolism but the pathophysiological
consequences of low leptin levels require further research,
especially considering the specificities of leptin secretion and
action in mice at early stages of postnatal development [40,41,45].
Similar considerations may be raised for resistin; in this case,
expression of resistin is known to be similar in BAT and WAT
depots from young rodents [46], and impaired levels of resistin in
serum are likely to be due to the strong reduction of resistin gene
expression in BAT in response to mtDNA depletion.
In summary, this study constitutes the first report on the role of
mtDNA depletion on adipose tissues in an in vivo experimental
model. We established that very low levels of mtDNA cause mild
impairment in BAT development, demonstrating the existence of
cellular regulatory mechanisms that mitigate the potentially
massive impairment in mitochondrial function that might
otherwise accompany profound mtDNA depletion. Because our
analyses required the use of very young mice (an intrinsic
limitation of the current mouse model) more refined research
models, such as conditional Tk2-null mice, will be required to
Figure 9. Tk2 mRNA expression and mtDNA levels in BAT and
WAT during mouse development. Bars are means 6 SEM (*P,0.05;
**P,0.01 for differences between adult BAT and BAT at different
development stages, and between 13-day-old WAT and adult WAT; 3–
8 mice/group).
doi:10.1371/journal.pone.0029691.g009
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determine the effects of TK2 deficiency in mtDNA in BAT and
WAT at more advanced stages of development, and to establish
whether the preferential impact of TK2 deficiency on mtDNA
depletion in BAT compared to WAT is due to the characteristic
temporal development profiles of these tissues in mice or to
different intrinsic sensitivities of these two types of adipose tissues
to TK2 deficiency and mtDNA alterations. Additional studies
employing rodent models of mtDNA deficiency will also be helpful
in determining the precise role of mtDNA depletion in the
lipodystrophy syndrome that manifests in some HIV-infected
patients undergoing antiretroviral treatment, a condition in which
WAT mtDNA levels are abnormally reduced. Importantly, the
existence of cellular mechanisms capable of alleviating the
consequences of profound mtDNA depletion in adipose tissue,
evidenced here, is also a subject that warrants further research, as
the molecular components of these mechanisms constitute
potential therapeutic targets for ameliorating disturbances in
mtDNA depletion syndromes in humans. Finally, the present study
evidences the existence of powerful mechanisms of mitochondrial
retrograde signaling in adipose tissue, by which mild alterations in
mitochondrial activity lead to profound abnormalities in gene
expression for adipokines and subsequently on blood adipokine
levels. This observation highlights that mitochondrial impairment
in adipose tissue may expand to systemic metabolism when, as
observed here, the nuclear gene expression affected by altered
mitochondrial signaling corresponds to components of the
endocrine function of the adipose tissue. This may be also relevant
to explain phenomena such as hypoleptinemia often observed in
HIV-1-infected patients with lipodystrophy [47] in association
with a significant, but quantitatively moderate, depletion of
mtDNA levels in adipose tissue.
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